Related Experiment Video
Updated: Dec 28, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Association between interleukin gene polymorphisms and multiple myeloma susceptibility.
Muhamaad Naveed Shahzad1, Iqra Ijaz2, Syed Shah Zaman Haider Naqvi3
1Stem Cell Laboratory, Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Interleukin gene polymorphisms, particularly IL-1 and IL-6, are linked to an increased risk of multiple myeloma (MM). Specific genetic variations may serve as important markers for MM risk assessment and potential therapeutic strategies.
Area of Science:
- Genetics
- Oncology
- Immunology
Background:
- Multiple myeloma (MM) is a hematological malignancy with complex genetic underpinnings.
- Interleukin (IL) genes play crucial roles in immune regulation and inflammation, potentially influencing cancer development.
- Understanding the association between IL gene polymorphisms and MM risk is vital for risk stratification and targeted therapies.
Purpose of the Study:
- To investigate the relationship between interleukin family gene polymorphisms and the risk of developing multiple myeloma (MM).
- To identify specific IL gene variants associated with increased MM susceptibility.
- To explore the potential of these polymorphisms as biomarkers for MM prognosis.
Main Methods:
- A retrospective observational study was conducted, analyzing data from sixteen case-control studies.
- The study included 2,597 patients diagnosed with MM and 3,851 healthy controls.
- Meta-analysis was employed to assess the association between various IL gene polymorphisms (IL-1, IL-6, IL-10) and MM risk.
Main Results:
- Specific genotypes of IL-6 and IL-1 GG were found to increase MM risk (OR=1.14 and OR=1.16, respectively).
- A significant association was observed between IL-6 and IL-10 T:C polymorphisms and MM risk (ORs ranging from 1.26 to 1.37).
- Polymorphisms in IL-1β1464G>C, IL-6572G>C, IL-1α-889C>T, and IL-1β-3737C>T showed significant associations with increased MM risk (P<0.05 and P<0.001).
Conclusions:
- Certain interleukin gene polymorphisms, including IL-1, IL-6, and IL-10, are significantly associated with an increased risk of multiple myeloma.
- Specific single nucleotide polymorphism (SNP) loci identified may serve as valuable genetic markers for MM screening.
- These findings suggest potential therapeutic strategies and prognostic indicators for patients with multiple myeloma based on genetic profiling.
More Related Videos
Related Concept Videos
Non-LTR Retrotransposons
Single Nucleotide Polymorphisms-SNPs
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Multiple Allele Traits

